Review
doi: 10.1007/BF02786511.Immune cell signaling aberrations in human lupus
Affiliations
- PMID:9724847
- DOI: 10.1007/BF02786511
Item in Clipboard
Review
Immune cell signaling aberrations in human lupus
S N Liossis et al. Immunol Res.1998 Aug.
Display options
Format
Display options
Format
Abstract
A large array of heterogeneous aberrations of the immune system have been described in systemic lupus erythematosus (SLE). Since the function and the fate of the immune system cells are governed principally by the biochemical events that follow ligation of specialized cell-surface receptors, we will review in this article recent developments in our understanding of abnormalities in the biochemistry of signals generated either by the antigen-receptor complex or by systems of costimulatory cell-surface molecules, like the CD28/CTLA4:CD80/CD86 and the CD40:CD40L pairs found on the surface membrane of lupus immune cells.
Similar articles
- Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.Nagafuchi H, Shimoyama Y, Kashiwakura J, Takeno M, Sakane T, Suzuki N.Nagafuchi H, et al.Clin Exp Rheumatol. 2003 Jan-Feb;21(1):71-7.Clin Exp Rheumatol. 2003.PMID:12673892
- Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.Bijl M, Horst G, Limburg PC, Kallenberg CG.Bijl M, et al.Ann Rheum Dis. 2001 May;60(5):523-6. doi: 10.1136/ard.60.5.523.Ann Rheum Dis. 2001.PMID:11302879Free PMC article.
- Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.García-Cózar FJ, Molina IJ, Cuadrado MJ, Marubayashi M, Peña J, Santamaría M.García-Cózar FJ, et al.Clin Exp Immunol. 1996 Apr;104(1):72-9. doi: 10.1046/j.1365-2249.1996.d01-648.x.Clin Exp Immunol. 1996.PMID:8603537Free PMC article.
- T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules.Yellin MJ, Thienel U.Yellin MJ, et al.Curr Rheumatol Rep. 2000 Feb;2(1):24-31. doi: 10.1007/s11926-996-0065-8.Curr Rheumatol Rep. 2000.PMID:11123036Review.
- The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.Mak A, Schwarz H.Mak A, et al.Cells. 2019 Sep 6;8(9):1044. doi: 10.3390/cells8091044.Cells. 2019.PMID:31500130Free PMC article.Review.
Cited by
- Targeting CD40L: a promising therapeutic approach.Daoussis D, Andonopoulos AP, Liossis SN.Daoussis D, et al.Clin Diagn Lab Immunol. 2004 Jul;11(4):635-41. doi: 10.1128/CDLI.11.4.635-641.2004.Clin Diagn Lab Immunol. 2004.PMID:15242934Free PMC article.Review.No abstract available.
- The cyclic AMP response element modulator {alpha} suppresses CD86 expression and APC function.Ahlmann M, Varga G, Sturm K, Lippe R, Benedyk K, Viemann D, Scholzen T, Ehrchen J, Müller FU, Seidl M, Matus M, Tsokos GC, Roth J, Tenbrock K.Ahlmann M, et al.J Immunol. 2009 Apr 1;182(7):4167-74. doi: 10.4049/jimmunol.0802976.J Immunol. 2009.PMID:19299714Free PMC article.
- Prolactin alters the mechanisms of B cell tolerance induction.Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E.Saha S, et al.Arthritis Rheum. 2009 Jun;60(6):1743-52. doi: 10.1002/art.24500.Arthritis Rheum. 2009.PMID:19479826Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Medical
Research Materials